Evidence map›Paper›PMID 37588796›Full record

Review3 Biotech2023

Crosstalk between

Prateek Sharma, Shravani M Phatak, Prisha Warikoo, Akshita Mathur, Shweta Mahant, Kunal Das, Rajashree Das

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in 3 Biotech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Progress in the treatment of duodenal cancer: A comprehensive review.World journal of gastrointestinal oncology · 2025
    Review
  4. BMJ open gastroenterology · 2024
    Article
  5. Review
  6. The toxic effects ofFood science & nutrition · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Prateek SharmaCenter for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, U.P. India.
Shravani M PhatakCenter for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, U.P. India.
Prisha WarikooCenter for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, U.P. India.
Akshita MathurCenter for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, U.P. India.
Shweta MahantCenter for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, U.P. India.
Kunal DasDepartment of Gastroenterology, Yashoda Super Speciality Hospital, Kaushambi, Ghaziabad, Uttar Pradesh India.
Rajashree DasCenter for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, U.P. India.ORCID 0000-0003-1202-4942
Amity University · INMax Super Speciality Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastroduodenal diseases have prevailed for a long time and more so due to dominance of gut bacteria

Indexed as

Duodenal ulcerGastric cancerGastritisGastroduodenal diseasesGut microbiotaHelicobacter pyloriPrevotella

Identifiers

PMID37588796
PMCPMC10425313
OpenAlexW4385802949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.